21th Annual Congress of International Drug Discovery Science and Technology (IDDST 2025)

The 21th Annual Congress of International Drug Discovery Science and Technology (IDDST 2025) discusses the latest advancements and strategies in drug discovery and related technologies.

Highlights

• Exploring cutting-edge biotherapies, including immune checkpoints and stem cell therapies.
• Unveiling breakthroughs in AI, quantum computing, and CRISPR for drug discovery.
• Examining the integration of traditional and modern medicine for innovative treatments.
• Focusing on personalized medicine and pharmacogenomics to optimize drug efficacy.
• Addressing challenges in drug delivery with emerging systems and technologies.
• Discussing natural product chemistry and marine-derived drug discovery.
• Highlighting R&D pipelines for diseases like cancer, CNS disorders, and metabolic diseases.
• Showcasing advancements in pharmaceutical manufacturing, including 3D printing and synthetic biology.
• Presenting the latest in omics technologies, bioinformatics, and microbiome-based drug discovery.

Who should Attend

• Academic researchers and scientists focused on pharmacology and drug design.
• Industry professionals working in R&D, manufacturing, or clinical trials.
• Executives and decision-makers in pharmaceutical and biotechnology companies.
• Healthcare providers and policymakers interested in drug discovery advancements.
• Regulatory experts and consultants in pharmaceutical compliance.
• Technology innovators exploring AI, machine learning, and quantum computing for healthcare.
• Entrepreneurs and investors in the field of biopharma and healthcare innovation.